montelukast
| Form | Strength |
|---|---|
| TABLET, CHEWABLE, ORAL | 5 mg |
| TABLET, ORAL | 10 mg |
| Pediatric Pharmacy Association 2025 KIDs List of Key Potentially Inappropriate Drugs in Pediatrics | |
|---|---|
| Medication: | montelukast (Singulair) |
| Key Potentially Inappropriate Drugs in Pediatrics (KIDs) List: Second Edition (Table 1) | |
| Drug | montelukast |
| Risk/Rationale | Sleep disturbances |
| Recommendation | Caution in 18 yr of age and younger |
| Quality of evidence: Very low, Strength of Recommendation: Weak | |